Lasya S
5.0
(1)
Studied at University of Pennsylvania
Works at BrainSpec Inc
Successful clients at
Available tomorrow at 3:00 PM UTC
Questions? Start chatting with this coach before you get started.
Work Experience
Principal Scientist
BrainSpec Inc
September 2025 - Present
I am a joint academic-industry scientist at BrainSpec and Brigham & Women's Hospital / Harvard Medical School. BrainSpec is a startup that spun out of the research at my postdoctoral lab in the Department of Radiology at BWH.
Postdoctoral Researcher
Harvard University
September 2025 - Present
I am a joint academic-industry scientist at BrainSpec and Brigham & Women's Hospital / Harvard Medical School. BrainSpec is a startup that spun out of the research at my postdoctoral lab in the Department of Radiology at BWH.
Data Science Intern
Merck
June 2023 - August 2023
Leveraged statistical genetics techniques and large-scale, multimodal datasets from biobanks and proprietary sources to build scalable pipelines for early discovery, prioritization, and validation of drug targets in a precision bioinformatics framework. Computational Biology, Statistical Genetics and +3 skills
PhD Candidate
University of Pennsylvania School of Medicine
2019 - 2025
Interdisciplinary PhD Candidate on the NIH T32 Predoctoral Training Grant Fellowship - Translational Neuroimaging of Alzheimer's Disease and Related Dementias. Machine Learning, Neuroimaging and +3 skills
Research Assistant
Brigham and Women's Hospital
August 2016 - August 2019
Education
University of Pennsylvania
Doctor of Philosophy - PhD, Bioengineering
2019 - 2025
Honors & Awards: - Penn Provost's Prize for Excellence in Teaching by Graduate Students, 2025 - NIH T32 Fellowship Program in Translational Neuroimaging, 2022-2024 - Christopher Clark Scholars Program at Penn Memory Center, 2020-2022
University of Pennsylvania
Master of Science in Engineering (MSE), Data Science
2019 - 2023
Yale University
Bachelor's Degree, Neuroscience
2015 - 2019
1 Review
Overall Rating
5.0
Lasya has helped Leland clients get into Johnson & Johnson